A5088103632- Iron Metabolism and Disorders
- Erythropoietin and Anemia Treatment
- Hemoglobinopathies and Related Disorders
- Antifungal resistance and susceptibility
- Neutropenia and Cancer Infections
- Fungal Infections and Studies
- Blood Pressure and Hypertension Studies
- Pharmaceutical Economics and Policy
- Cystic Fibrosis Research Advances
- Biotechnology and Related Fields
- Healthcare Systems and Practices
- Infectious Diseases and Mycology
- Parasitic Diseases Research and Treatment
- Blood donation and transfusion practices
- Healthcare Systems and Reforms
- Genetic Neurodegenerative Diseases
- Central Venous Catheters and Hemodialysis
- Biosimilars and Bioanalytical Methods
- Global Cancer Incidence and Screening
- Potassium and Related Disorders
- Nutrition and Health in Aging
- Hepatitis C virus research
- Nutritional Studies and Diet
- Family and Patient Care in Intensive Care Units
- Bacterial Infections and Vaccines
Centre Hospitalier Universitaire de Grenoble
2025
École Nationale Supérieure d'Hydraulique
2024
Centre Orthopédique Santy
2018-2023
University of Blida
2023
Hôpital Mustapha Pacha
2023
Creative Commons
2023
Centre de Recherche Nucléaire d’Alger
2016-2019
Public Central Hospital of Matto Ishikawa
2012
Chugai Pharma (United States)
2012
King's College Hospital NHS Foundation Trust
2012
Abstract BACKGROUND. Invasive aspergillosis (IA) has a poor prognosis in immunocompromised patients. Combinations of drugs that act on different targets are expected to improve the clinical efficacy separate compounds. METHODS. Patients with proven or probable IA were randomized prospective, open pilot study receive either combination liposomal amphotericin B (AmB) at standard dose (3 mg/kg daily) and caspofungin monotherapy high‐dose AmB regimen (10 daily). RESULTS. Thirty patients (21 men...
Introduction The optimal method for removing the endotracheal tube (ETT) during extubation in intensive care unit (ICU) remains uncertain. Two methods are described ETT ICU, namely ‘Traditional technique’ with continuous aspiration cuff deflation and removal; ‘PEEP’ method, which consists applying positive end-expiratory pressure (PEEP) before removal. Our hypothesis is that PEEP ICU would improve clinical outcome. Methods analysis This a prospective, multicentre, randomised, open-label,...
To evaluate the economic impact of intravenous iron (in form preparation ferric carboxymaltose) in three different clinical settings deficiency anemia: chemotherapy-induced anemia breast cancer, digestive and perioperative knee hip surgery.The model compared usual therapeutic strategies without including iron, each selected. Costs related to treatment by erythropoiesis-stimulating agents (ESA), blood transfusion, were estimated inside setting. Cost savings calculated from French healthcare...
diagnostic methods and management of iron deficiency anemia in clinical practice Algeria is poorly known.we conducted a cross-sectional survey among doctors different specialties treating patients with 2016.data analysis was based on 349 questionnaires which were validated (anesthesia/resuscitation: 39; obstetrics gynaecology: 111; oncology/Hematology: 71; hepato-gastroenterology: 64; cardiology: 36; internal medicine: 28). All combined, 73% (254/349) physicians thought that at least 30%...
Abstract BACKGROUND: Iron deficiency (ID) and ID anemia (IDA) are widespread health issues affecting a significant number of women in Algeria, particularly during pregnancy. With lack clear, localized guidelines for managing IDA the need consensus on eligibility criteria ferric carboxymaltose (FCM) usage obstetrics was recognized. AIMS AND OBJECTIVES: In this context, national expert panel aimed to establish FCM as optimal intravenous (IV) iron treatment with ID/IDA obstetrics, based shared...
To evaluate the economic impact of intravenous iron (ferric carboxymaltose; Ferinject) in chemotherapy-induced ferriprive anemia breast and gastrointestinal cancer. We used an model which compared usual therapeutic strategies with or without iron. Costs related to treatment by ESA, blood transfusion were estimated compared. Cost savings calculated from French healthcare payer perspective. Data included obtained scientific literature, public health agencies medical experts. Impact Ferinject...
To evaluate the cost of anemia management according to hemoglobin level variability in hemodialysis (HD) patients. This was a retrospective study based on computerized medical files, (Hemodial® software database), which included 636 HD patients 5 dialysis centers 2009. Patients were evaluable if they regularly hemodialyzed, had at least one Hb recorded per month and monitored for 4 months. “Annual values” categorized their monthly mean (Ideal [10 ≤ 12 g/dL; n=119]; High [Hb >12 n=61] Low <...
e20654 Background: Iron deficiency with anemia is a frequent complication in cancer.Ferric carboxymaltose (FCM) approved for the correction of iron France since beginning 2011. This observational multicenter study has recruited 2 cohorts patients to describe FCM use daily practice hematological malignancies or solid tumors. Methods: Cohort 1 (retrospective): 450 treated 2010 any intravenous (IV) red blood cell transfusion (BT); (prospective): after July 1, Patient characteristics are...
Objectives: There are limited data on the management of hypertension (HT) in Algeria. The aim this study was to assess, current medical practice, use and benefits ambulatory blood pressure monitoring (ABPM) for diagnosis HT. Methods: prospective, observational, multicenter performed 2017. Patients aged ≥ 18 years with suspected or treated HT were included. A 24-hour ABPM at baseline all patients. Therapeutic decision taken by physician according results patients then followed up 6 weeks....
Objective : Evaluate the hemoglobin (Hb) target values in hemodialysis (HD) patients treated with erythropoiesis-stimulating agents (ESA). Methods: Records of anemia parameters HD during year 2012 5 French dialysis centers were retrospectively analyzed. Patients stratified into “annual Hb categories” according to their monthly mean Hb: Low ( 12 g/dL) if they spent ≥ 75% time respective category; otherwise